Eshini Anne-Merie Panditharatna, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioma | 13 | 2022 | 3401 | 1.320 |
Why?
|
| Brain Stem Neoplasms | 6 | 2019 | 204 | 0.940 |
Why?
|
| Epigenomics | 2 | 2020 | 903 | 0.470 |
Why?
|
| Histones | 7 | 2022 | 2599 | 0.370 |
Why?
|
| Brain Neoplasms | 5 | 2021 | 8863 | 0.290 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3647 | 0.280 |
Why?
|
| Mutation | 8 | 2022 | 29786 | 0.240 |
Why?
|
| Vaccinia | 1 | 2022 | 76 | 0.210 |
Why?
|
| Neuroblastoma | 2 | 2022 | 1226 | 0.190 |
Why?
|
| Autopsy | 4 | 2020 | 1020 | 0.190 |
Why?
|
| Genomics | 1 | 2015 | 5720 | 0.170 |
Why?
|
| Body Fluids | 1 | 2019 | 319 | 0.150 |
Why?
|
| Pons | 2 | 2016 | 245 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 3 | 2022 | 6171 | 0.150 |
Why?
|
| DNA Helicases | 1 | 2022 | 859 | 0.150 |
Why?
|
| Mammals | 1 | 2022 | 1143 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2020 | 8428 | 0.130 |
Why?
|
| Neoplastic Stem Cells | 1 | 2022 | 1376 | 0.120 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 602 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 17446 | 0.110 |
Why?
|
| Child | 13 | 2022 | 77709 | 0.110 |
Why?
|
| Leukemia | 1 | 2020 | 1511 | 0.100 |
Why?
|
| Genetic Heterogeneity | 1 | 2015 | 733 | 0.100 |
Why?
|
| Niacinamide | 1 | 2013 | 417 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 2727 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2012 | 0.100 |
Why?
|
| Neoplasms | 1 | 2020 | 21683 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2015 | 694 | 0.090 |
Why?
|
| Chromatin | 1 | 2020 | 2934 | 0.080 |
Why?
|
| Telomere | 1 | 2014 | 910 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 5853 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2022 | 3523 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2020 | 4286 | 0.070 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 13695 | 0.070 |
Why?
|
| Indoles | 1 | 2013 | 1839 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5442 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 11031 | 0.060 |
Why?
|
| Humans | 17 | 2022 | 744343 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2022 | 12208 | 0.050 |
Why?
|
| Age Factors | 1 | 2018 | 18370 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2013 | 2529 | 0.050 |
Why?
|
| Vaccinia virus | 1 | 2022 | 349 | 0.050 |
Why?
|
| Methionine | 1 | 2022 | 590 | 0.050 |
Why?
|
| Feasibility Studies | 2 | 2021 | 5078 | 0.040 |
Why?
|
| Nervous System | 1 | 2022 | 554 | 0.040 |
Why?
|
| RNA | 2 | 2022 | 2749 | 0.040 |
Why?
|
| Telomerase | 2 | 2014 | 730 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2022 | 13033 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 265 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11524 | 0.040 |
Why?
|
| Neoplasm, Residual | 1 | 2022 | 973 | 0.040 |
Why?
|
| Child, Preschool | 5 | 2020 | 41006 | 0.040 |
Why?
|
| Reference Standards | 1 | 2021 | 1025 | 0.040 |
Why?
|
| Animals | 3 | 2022 | 168757 | 0.030 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2016 | 74 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 1878 | 0.030 |
Why?
|
| Activin Receptors, Type I | 1 | 2016 | 142 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 9239 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2020 | 2716 | 0.030 |
Why?
|
| Cerebrum | 1 | 2016 | 137 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2016 | 337 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 35421 | 0.030 |
Why?
|
| Stereotaxic Techniques | 1 | 2016 | 536 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2022 | 2504 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 940 | 0.030 |
Why?
|
| Disease Progression | 2 | 2022 | 13284 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 6314 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3557 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 9438 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2915 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2022 | 2899 | 0.020 |
Why?
|
| Zebrafish | 1 | 2022 | 2994 | 0.020 |
Why?
|
| Brain Stem | 1 | 2016 | 846 | 0.020 |
Why?
|
| Recurrence | 1 | 2022 | 8340 | 0.020 |
Why?
|
| Young Adult | 4 | 2020 | 56430 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3586 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2013 | 572 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 1654 | 0.020 |
Why?
|
| Astrocytoma | 1 | 2014 | 790 | 0.020 |
Why?
|
| Adolescent | 4 | 2020 | 85781 | 0.020 |
Why?
|
| Prognosis | 2 | 2021 | 29063 | 0.020 |
Why?
|
| Tissue and Organ Procurement | 1 | 2015 | 896 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 1836 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2938 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 16689 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2019 | 8324 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 14722 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 4851 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 2948 | 0.020 |
Why?
|
| Infant | 2 | 2020 | 35136 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 4933 | 0.020 |
Why?
|
| Biopsy | 1 | 2016 | 6756 | 0.020 |
Why?
|
| Female | 6 | 2020 | 380194 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 6895 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6538 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 19905 | 0.010 |
Why?
|
| Male | 5 | 2020 | 350118 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2016 | 6669 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8949 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16365 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 5172 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2016 | 63114 | 0.010 |
Why?
|
| Adult | 2 | 2020 | 214055 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 81183 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 40075 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 23403 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 77449 | 0.000 |
Why?
|